Aquestive Therapeutics (AQST) Capital Expenditures Growth (3y) (2020 - 2026)
Aquestive Therapeutics (AQST) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 34.64% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 147.53% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.86% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -61.38% |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | 196.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196.25% |
| Dec 31, 2025 | 48.42% |
| Sep 30, 2025 | 22.00% |
| Jun 30, 2025 | -27.58% |
| Mar 31, 2025 | 9.09% |
| Dec 31, 2024 | -69.58% |
| Sep 30, 2024 | 20.16% |
| Jun 30, 2024 | -29.06% |
| Mar 31, 2024 | -34.46% |
| Dec 31, 2023 | -59.22% |
| Sep 30, 2023 | 58.39% |
| Jun 30, 2023 | 94.65% |
| Mar 31, 2023 | -75.19% |
| Dec 31, 2022 | -32.88% |
| Sep 30, 2022 | 33.60% |
| Jun 30, 2022 | 83.26% |
| Mar 31, 2022 | -34.84% |
| Dec 31, 2021 | 2.84% |
| Sep 30, 2021 | -42.99% |
| Jun 30, 2021 | -32.36% |